NunaBio - company
4 known investors
NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform. It provides software-orchestrated, distributed DNA manufacturing infrastructure for producing complex DNA without process redevelopment.
Investors · 4
Competitors · 4
by search overlapNosis Bio4 shared keywordsNosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
Nuvation Bio3 shared keywordsNuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed. Its pipeline of therapeutic candidates addresses drug resistance and limited efficacy of current cancer therapies.
bio3 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Mana Bio3 shared keywordsMana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines. The company aims to unlock RNA-based treatments for genetic diseases with unmet medical needs.
Companies competing with NunaBio - company for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NunaBio - company do?
- NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform. It provides software-orchestrated, distributed DNA manufacturing infrastructure for producing complex DNA without process redevelopment.
- Who are NunaBio - company's investors?
- NunaBio - company's investors include EMV Capital, Martlet Capital, Maven Capital Partners, Northstar Ventures.



